CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 175 filers reported holding CONMED CORP in Q1 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,534,361 | +704.6% | 25,130 | +1085.9% | 0.06% | +326.7% |
| Q1 2022 | $315,000 | +38.2% | 2,119 | +27.6% | 0.02% | -21.1% |
| Q2 2021 | $228,000 | -58.8% | 1,661 | -66.4% | 0.02% | -67.8% |
| Q4 2020 | $554,000 | +0.5% | 4,942 | -35.4% | 0.06% | +55.3% |
| Q2 2020 | $551,000 | -56.8% | 7,647 | -65.7% | 0.04% | -59.1% |
| Q1 2020 | $1,276,000 | +129.9% | 22,280 | +349.0% | 0.09% | +181.8% |
| Q4 2019 | $555,000 | -2.8% | 4,962 | -27.7% | 0.03% | -19.5% |
| Q1 2019 | $571,000 | +149.3% | 6,860 | +137.4% | 0.04% | +141.2% |
| Q3 2018 | $229,000 | -41.0% | 2,890 | -62.0% | 0.02% | -60.5% |
| Q4 2017 | $388,000 | -48.3% | 7,610 | -55.0% | 0.04% | -55.2% |
| Q1 2017 | $751,000 | +147.9% | 16,900 | +134.3% | 0.10% | +166.7% |
| Q1 2016 | $303,000 | -27.5% | 7,213 | -24.1% | 0.04% | -2.7% |
| Q4 2015 | $418,000 | +32.7% | 9,500 | +43.9% | 0.04% | +37.0% |
| Q3 2015 | $315,000 | – | 6,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |